Piccart MJ - Search Results

1

Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.

Azim HA Jr, Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, Haibe-Kains B, Piccart MJ, Sotiriou C, Loi S. Azim HA Jr, et al. Among authors: piccart mj. Clin Cancer Res. 2012 Mar 1;18(5):1341-51. doi: 10.1158/1078-0432.CCR-11-2599. Epub 2012 Jan 18. Clin Cancer Res. 2012. PMID: 22261811 Free article.

2

Ureteral obstruction in patients with breast cancer.

Recloux P, Weiser M, Piccart M, Sculier JP. Recloux P, et al. Cancer. 1988 May 1;61(9):1904-7. doi: 10.1002/1097-0142(19880501)61:9<1904::aid-cncr2820610930>3.0.co;2-1. Cancer. 1988. PMID: 3355980

3

Estrogen receptor status and estradiol sensitivity of MCF-7 cells in exponential growth phase.

Madeddu L, Legros N, Devleeschouwer N, Bosman C, Piccart MJ, LeClercq G. Madeddu L, et al. Among authors: piccart mj. Eur J Cancer Clin Oncol. 1988 Mar;24(3):385-90. doi: 10.1016/s0277-5379(98)90007-4. Eur J Cancer Clin Oncol. 1988. PMID: 3383942

4

Tamoxifen aziridine labeling of the estrogen receptor-potential utility in detecting biologically aggressive breast tumors.

Trivedi S, Piccart M, Muquardt C, Gilot N, Hadiy S, Patel D, Leclercq G. Trivedi S, et al. Breast Cancer Res Treat. 1996;40(3):231-41. doi: 10.1007/BF01806811. Breast Cancer Res Treat. 1996. PMID: 8883965

5

Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome.

Lespagnard L, Gancberg D, Rouas G, Leclercq G, de Saint-Aubain Somerhausen N, Di Leo A, Piccart M, Verhest A, Larsimont D. Lespagnard L, et al. Int J Cancer. 1999 Jun 21;84(3):309-14. doi: 10.1002/(sici)1097-0215(19990621)84:3<309::aid-ijc19>3.0.co;2-3. Int J Cancer. 1999. PMID: 10371352

6

Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 cases.

Gancberg D, Lespagnard L, Rouas G, Paesmans M, Piccart M, Di Leo A, Nogaret JM, Hertens D, Verhest A, Larsimont D. Gancberg D, et al. Am J Clin Pathol. 2000 May;113(5):675-82. doi: 10.1309/0F58-0GRX-FK4R-A6VA. Am J Clin Pathol. 2000. PMID: 10800400

7

EORTC 10941: A phase II study of liarozole in postmenopausal patients with 'chemotherapy-resistant' or 'potentially hormone sensitive' metastatic breast cancer.

Hamilton A, Roy JA, Beex L, Piccart M, Mauriac L, Coleman R, Paridaens R, Boes GH, van Vreckem A, Palmer P, Klijn J. Hamilton A, et al. Breast Cancer Res Treat. 2000 Mar;60(2):181-8. doi: 10.1023/a:1006398518037. Breast Cancer Res Treat. 2000. PMID: 10845281 Clinical Trial.

8

[Breast cancer and herceptin].

Cornez N, Piccart MJ. Cornez N, et al. Among authors: piccart mj. Bull Cancer. 2000 Nov;87(11):847-58. Bull Cancer. 2000. PMID: 11125293 Free article. Review. French.

9

Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer.

Piccart MJ, Di Leo A, Beauduin M, Vindevoghel A, Michel J, Focan C, Tagnon A, Ries F, Gobert P, Finet C, Closon-Dejardin MT, Dufrane JP, Kerger J, Liebens F, Beauvois S, Bartholomeus S, Dolci S, Lobelle JP, Paesmans M, Nogaret JM. Piccart MJ, et al. J Clin Oncol. 2001 Jun 15;19(12):3103-10. doi: 10.1200/JCO.2001.19.12.3103. J Clin Oncol. 2001. PMID: 11408507 Clinical Trial.

10

Proposed treatment guidelines for HER2-positive metastatic breast cancer in Europe.

Piccart MJ. Piccart MJ. Ann Oncol. 2001;12 Suppl 1:S89-94. doi: 10.1093/annonc/12.suppl_1.s89. Ann Oncol. 2001. PMID: 11521728 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

606 results

Search Page

Filters